1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma. Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhang S, Yue M, Shu R, Cheng H and Hu P:
Recent advances in the management of hepatocellular carcinoma. J
BUON. 21:307–311. 2016.PubMed/NCBI
|
4
|
Vibert E, Schwartz M and Olthoff KM:
Advances in resection and transplantation for hepatocellular
carcinoma. J Hepatol. 72:262–276. 2020. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lei X, Xu JF, Chang RM, Fang F, Zuo CH and
Yang LY: JARID2 promotes invasion and metastasis of hepatocellular
carcinoma by facilitating epithelial-mesenchymal transition through
PTEN/AKT signaling. Oncotarget. 7:40266–40284. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sivakumar S and Gorbsky GJ:
Phosphatase-regulated recruitment of the spindle- and
kinetochore-associated (Ska) complex to kinetochores. Biol Open.
6:1672–1679. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Abad MA, Zou J, Medina-Pritchard B, Nigg
EA, Rappsilber J, Santamaria A and Jeyaprakash AA: Ska3 ensures
timely mitotic progression by interacting directly with
microtubules and ska1 microtubule binding domain. Sci Rep.
6:340422016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Raaijmakers JA, Tanenbaum ME, Maia AF and
Medema RH: RAMA1 is a novel kinetochore protein involved in
kinetochore-microtubule attachment. J Cell Sci. 122:2436–2445.
2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ohta S, Bukowski-Wills JC, Sanchez-Pulido
L, de Lima Alves F, Wood L, Chen ZA, Platani M, Fischer L, Hudson
DF, Ponting CP, et al: The protein composition of mitotic
chromosomes determined using multiclassifier combinatorial
proteomics. Cell. 142:810–821. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang Q, Sivakumar S, Chen Y, Gao H, Yang
L, Yuan Z, Yu H and Liu H: Ska3 phosphorylated by Cdk1 binds Ndc80
and recruits ska to kinetochores to promote mitotic progression.
Curr Biol. 27:1477–1484. 2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Chuang TP, Wang JY, Jao SW, Wu CC, Chen
JH, Hsiao KH, Lin CY, Chen SH, Su SY, Chen YJ, et al:
Over-Expression of AURKA, SKA3 and DSN1 contributes to colorectal
adenoma to carcinoma progression. Oncotarget. 7:45803–45818. 2016.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Pesson M, Volant A, Uguen A, Trillet K, De
La Grange P, Aubry M, Daoulas M, Robaszkiewicz M, Le Gac G, Morel
A, et al: A gene expression and pre-mRNA splicing signature that
marks the adenoma-adenocarcinoma progression in colorectal cancer.
PLoS One. 9:e877612014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lee M, Williams KA, Hu Y, Andreas J, Patel
SJ, Zhang S and Crawford NP: GNL3 and SKA3 are novel prostate
cancer metastasis susceptibility genes. Clin Exp Metastasis.
32:769–782. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tang D, Zhao X, Zhang L, Wang Z and Wang
C: Identification of hub genes to regulate breast cancer metastasis
to brain by bioinformatics analyses. J Cell Biochem. 120:9522–9531.
2019. View Article : Google Scholar : PubMed/NCBI
|
15
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Brookland RK, Meyer L, Gress DM, Byrd
DR and Winchester DP: The eighth edition AJCC cancer staging
manual: Continuing to build a bridge from a population-based to a
more ‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lecluyse EL and Alexandre E: Isolation and
culture of primary hepatocytes from resected human liver tissue.
Methods Mol Biol. 640:57–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Vondran FW, Katenz E, Schwartlander R,
Morgul MH, Raschzok N, Gong X, Cheng X, Kehr D and Sauer IM:
Isolation of primary human hepatocytes after partial hepatectomy:
Criteria for identification of the most promising liver specimen.
Artif Organs. 32:205–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen SP, Zhang LS, Fu BS, Zeng XC, Yi HM
and Jiang N: Prostate tumor overexpressed 1 is a novel prognostic
marker for hepatocellular carcinoma progression and overall patient
survival. Medicine (Baltimore). 94:e4232015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Debrabant B: The null hypothesis of GSEA,
and a novel statistical model for competitive gene set analysis.
Bioinformatics. 33:1271–1277. 2017.PubMed/NCBI
|
21
|
Tsuzuki S and Seto M: Expansion of
functionally defined mouse hematopoietic stem and progenitor cells
by a short isoform of RUNX1/AML1. Blood. 119:727–735. 2012.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
23
|
Shomer NH, Allen-Worthington KH, Hickman
DL, Jonnalagadda M, Newsome JT, Slate AR, Valentine H, Valentine H
and Wilkinson M: Review of rodent euthanasia methods. J Am Assoc
Lab Anim Sci. 59:242–253. 2020. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chen S, Zhou Q, Guo ZN, Wang Y, Wang L,
Liu X, Lu M, Ju L, Xiao Y and Wang X: Inhibition of MELK produces
potential anti-tumour effects in bladder cancer by inducing G1/S
cell cycle arrest via the ATM/CHK2/p53 pathway. J Cell Mol Med.
24:1804–1821. 2019. View Article : Google Scholar : PubMed/NCBI
|
25
|
Doerfler W, Hohlweg U, Müller K, Remus R,
Heller H and Hertz J: Foreign DNA integration--perturbations of the
genome--oncogenesis. Ann N Y Acad Sci. 945:276–288. 2001.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Helgeson LA, Zelter A, Riffle M, MacCoss
MJ, Asbury CL and Davis TN: The human ska complex and Ndc80 complex
interact to form a load-bearing assembly that strengthens
kinetochore-microtubule attachments. Proc Natl Acad Sci USA.
115:2740–2745. 2018. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sivakumar S, Daum JR, Tipton AR, Rankin S
and Gorbsky GJ: The spindle and kinetochore-associated (Ska)
complex enhances binding of the anaphase-promoting
complex/cyclosome (APC/C) to chromosomes and promotes mitotic exit.
Mol Biol Cell. 25:594–605. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Shi Y, Guo S, Wang Y, Liu X, Li Q and Li
T: Lamprey prohibitin2 arrest G2/M phase transition of heLa cells
through down-regulating expression and phosphorylation level of
cell cycle proteins. Sci Rep. 8:1–8. 2018.PubMed/NCBI
|
29
|
Hou Y, Wang Z, Huang S, Sun C, Zhao J, Shi
J, Li Z, Wang Z, He X, Tam NL and Wu L: SKA3 Promotes tumor growth
by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
Cell Death Dis. 10:9292019. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kanno S, Kurauchi K, Tomizawa A, Yomogida
S and Ishikawa M: Pifithrin-Alpha has a p53-independent
cytoprotective effect on docosahexaenoic acid-induced cytotoxicity
in human hepatocellular carcinoma HepG2 cells. Toxicol Lett.
232:393–402. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Liu L, Zhang P, Bai M, He L, Zhang L, Liu
T, Yang Z, Duan M, Liu M, Liu B, et al: P53 Upregulated by HIF-1α
promotes hypoxia-induced G2/M arrest and renal fibrosis in vitro
and in vivo. J Mol Cell Biol. 11:371–382. 2019. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lynn AS: Inhibition of E2F1 activity and
cell cycle progression by arsenic via retinoblastoma protein. Cell
Cycle. 16:2058–2072. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Wang L, Chen H, Wang C, Hu Z and Yan S:
Negative regulator of E2F transcription factors links cell cycle
checkpoint and DNA damage repair. Proc Natl Acad Sci USA.
115:E3837–E3845. 2018. View Article : Google Scholar : PubMed/NCBI
|
34
|
Mori K, Uchida T, Fukumura M, Tamiya S,
Higurashi M, Sakai H, Ishikawa F and Shibanuma M: Linkage of E2F1
transcriptional network and cell proliferation with respiratory
chain activity in breast cancer cells. Cancer Sci. 107:963–971.
2016. View Article : Google Scholar : PubMed/NCBI
|
35
|
Nikolai BC, Lanz RB, York B, Dasgupta S,
Mitsiades N, Creighton CJ, Tsimelzon A, Hilsenbeck SG, Lonard DM,
Smith CL and O'Malley BW: HER2 signaling drives DNA anabolism and
proliferation through SRC-3 phosphorylation and E2F1-regulated
genes. Cancer Res. 76:1463–1475. 2016. View Article : Google Scholar : PubMed/NCBI
|
36
|
Cataldo A, Cheung DG, Balsari A, Tagliabue
E, Coppola V, Iorio MV, Palmieri D and Croce CM: MiR-302b enhances
breast cancer cell sensitivity to cisplatin by regulating E2F1 and
the cellular DNA damage response. Oncotarget. 7:786–797. 2016.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Sheldon LA: Inhibition of E2F1 activity
and cell cycle progression by arsenic via retinoblastoma protein.
Cell Cycle. 16:2058–2072. 2017. View Article : Google Scholar : PubMed/NCBI
|
38
|
Takahashi Y, Rayman JB and Dynlacht BD:
Analysis of promoter binding by the E2F and pRB families in vivo:
Distinct E2F proteins mediate activation and repression. Genes Dev.
14:804–816. 2000.PubMed/NCBI
|
39
|
Datta D, Anbarasu K, Rajabather S, Priya
RS, Desai P and Mahalingam S: Nucleolar GTP-binding protein-1
(NGP-1) promotes G1 to S phase transition by activating
cyclin-dependent kinase inhibitor p21 Cip1/Waf1. J Biol Chem.
290:21536–21552. 2015. View Article : Google Scholar : PubMed/NCBI
|
40
|
Chang MM, Lai MS, Hong SY, Pan BS, Huang
H, Yang SH, Wu CC, Sun HS, Chuang JI, Wang CY and Huang BM:
FGF9/FGFR2 increase cell proliferation by activating ERK1/2,
Rb/E2F1, and cell cycle pathways in mouse leydig tumor cells.
Cancer Sci. 109:3503–3518. 2018. View Article : Google Scholar : PubMed/NCBI
|
41
|
Hu R, Wang MQ, Niu WB, Wang YJ, Liu YY,
Liu LY, Wang M, Zhong J, You HY, Wu XH, et al: SKA3 promotes cell
proliferation and migration in cervical cancer by activating the
PI3K/Akt signaling pathway. Cancer Cell Int. 18:1832018. View Article : Google Scholar : PubMed/NCBI
|